Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effect of Intravenous Anesthetics on Fear Learning and Memory
This study is currently recruiting participants.
Study NCT00767767   Information provided by Weill Medical College of Cornell University
First Received: October 3, 2008   Last Updated: October 6, 2008   History of Changes

October 3, 2008
October 6, 2008
October 2008
December 2009   (final data collection date for primary outcome measure)
  • Changes in skin conductance [ Time Frame: Throughout Study ] [ Designated as safety issue: No ]
  • Changes in the eye-blink reflex following an auditory startle probe [ Time Frame: Throughout Study ] [ Designated as safety issue: No ]
  • Changes in heart-rate variability [ Time Frame: Throughout Study ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00767767 on ClinicalTrials.gov Archive Site
 
 
 
The Effect of Intravenous Anesthetics on Fear Learning and Memory
The Effect of Intravenous Anesthetics on Fear Learning and Memory

People often develop fearful responses to things, but have no conscious control over the fear (e.g. phobias). This is a basic form of unconscious memory, called âââ€-¬Ã<Å"fear conditioningâââ€-‰"¢. Intravenous anesthetic drugs have remarkable effects on conscious memory, but it is unknown whether they have similar effects on these unconscious fear memories.

To address this question, the investigators will study 90 healthy adult volunteer subjects. The subject is given a very low dose of an anesthetic drug intravenously (i.e. through the bloodstream). The dose is so low that the subject might not even be able tell if they are getting the drug. While they are receiving the drug, the subject will perform a series of memory tests and a fear conditioning experiment, which are set up like a very simple computer game. To create the âââ€-¬Ã<Å"fear responseâââ€-‰"¢, subjects will occasionally receive a mildly uncomfortable shock to their arm. The subject is able to determine the highest level of shock that they will receive.

The investigators are doing this study because the investigators wish to know exactly how the drugs affect the way people process fear and emotion. This knowledge might one day be used in the treatment of some psychiatric disorders.

 
 
Interventional
Basic Science, Randomized, Single Blind (Subject), Placebo Control, Parallel Assignment, Pharmacodynamics Study
Phobias
  • Drug: Propofol
  • Drug: Placebo
  • Drug: Thiopental
  • Drug: Midazolam
  • Drug: Dexmedetomidine
  • Placebo Comparator: Saline Infusion.
  • Active Comparator: Anesthetic Drug Infusion.
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
90
December 2009
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age between 18 and 50
  • right handed
  • minimum of high school education
  • fluent in English
  • normal vocabulary

Exclusion Criteria:

  • any significant medical or psychiatric comorbidity (e.g. asthma, diabetes, hypertension, depression, high anxiety)â€"subjects must be in excellent health such that they would be classified as American Society of Anesthesiologists Physical Status Class I
  • deficit in vision or hearing that would impede the study
  • allergies to any of the study drugs, to soybeans, or to eggs
  • a history of head trauma
  • a family history of major psychiatric illness
  • body mass index > 30 kg/m2
  • a recent history of recreational drug use
  • prior exposure to the study materials
  • pregnancy
  • a personal or family history of any porphyria
  • (xi) failure to exhibit a skin conductance response to deep inspiration; (xii) the ability to read native Chinese characters
  • assessment by the investigators that the subject may be unable to cooperate or comply with the study requirements.
Both
18 Years to 50 Years
Yes
Contact: Jackie Bogan, B.A. 212-746-9419 jab2035@med.cornell.edu
United States
 
NCT00767767
Kane Pryor, Weill Cornell Medical College
0710009434
Weill Medical College of Cornell University
 
Principal Investigator: Kane Pryor, MD Weill Cornell Medical College
Weill Medical College of Cornell University
October 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP